Latest
1 hour ago
Conservatives Weave Anti-Abortion Fantasyland To Allow Emergency Room Abortion Bans
23 hours ago
Prosecutors Build Towards The Stormy Daniels Hush-Money Scheme
2 days ago
Trump Opening Statements: ‘Election Fraud,’ Fake News, And An Appeal To Exhaustion
2 days ago
Liberal Justices Come Out Swinging In Uphill Battle Over Criminalizing Homelessness

Vilified Pharma CEO Shkreli Calls Fraud Charges Against Him ‘Baseless’

Martin Shkreli, center, leaves the courthouse after his arraignment in New York, Thursday, Dec. 17, 2015. Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical ... Martin Shkreli, center, leaves the courthouse after his arraignment in New York, Thursday, Dec. 17, 2015. Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, was arrested Thursday on securities fraud charges unrelated to the furor. (AP Photo/Seth Wenig) MORE LESS
By Sara Jerde
|
December 19, 2015 3:01 p.m.
Start your day with TPM.
Sign up for the Morning Memo newsletter

Martin Shkreli, the former hedge fund manager and pharmaceutical CEO, tweeted Saturday that the fraud charges against him were “baseless.”

Shkreli was arrested Thursday on securities fraud charges and released on a $5 million bond. The 32 year-old made headlines this summer when it was reported that he raised the price of a life-saving drug by 5,000 percent. After the backlash, the company vowed to lower the price.

Here’s Shkreli’s tweet:

Start your day with TPM.
Sign up for the Morning Memo newsletter
Author Headshot
Sara Jerde (@SaraJerde)  Sara Jerde is a newswriter based in New York. Her bylines have appeared in The Star-Ledger, The Chronicle of Higher Education and The Columbus Dispatch. She graduated from Ohio University. Send emails to sara@talkingpointsmemo.com and follow her @SaraJerde.
 Have a tip? Send it Here!
Latest Livewire
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: